Literature DB >> 22622094

Prevalence of stroke--United States, 2006-2010.

.   

Abstract

In 2008, mortality from stroke was the fourth leading cause of death in the United States, and stroke was a leading cause of long-term severe disability. Nearly half of older stroke survivors experience moderate to severe disability. Care for stroke survivors cost an estimated $18.8 billion in the United States during 2008, and lost productivity and premature mortality cost an additional $15.5 billion. A 3.6% decline in stroke mortality during 2007-2008 means that the prevalence of stroke (defined in this report as the percentage of noninstitutionalized persons who have ever experienced stroke) will increase if stroke incidence and the mean length of post-stroke survival does not decrease and the proportion of institutionalized stroke survivors does not change. Measuring the prevalence of stroke at the state level enables CDC and state health officials to target resources to populations or regions with high prevalence. A previous report of state-level stroke prevalence used 2005 Behavioral Risk Factor Surveillance System (BRFSS) data. To measure recent trends in stroke prevalence by sociodemographic characteristics and state of residence, CDC analyzed 2006-2010 data from BRFSS. This report describes the results of that analysis, which indicated that during this period, overall self-reported stroke prevalence did not change. However, consistent with findings in the previous report, there were disparities in stroke prevalence identified by age, race/ethnicity, and level of education. Specifically, older adults, blacks, American Indians/Alaska Natives, persons with lower levels of education, and persons living in the southeastern United States had higher stroke prevalence.

Entities:  

Mesh:

Year:  2012        PMID: 22622094

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  69 in total

1.  Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Shlomit Yust-Katz; Yvo A Rodriguez; Pedro Garciarena; Elsa M Rodarte; Ivo W Tremont-Lukats
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

3.  Surveillance for Certain Health Behaviors and Conditions Among States and Selected Local Areas - Behavioral Risk Factor Surveillance System, United States, 2015.

Authors:  Cassandra M Pickens; Carol Pierannunzi; William Garvin; Machell Town
Journal:  MMWR Surveill Summ       Date:  2018-06-29

4.  Williams syndrome predisposes to vascular stiffness modified by antihypertensive use and copy number changes in NCF1.

Authors:  Beth A Kozel; Joshua R Danback; Jessica L Waxler; Russell H Knutsen; Lisa de Las Fuentes; Gyorgy S Reusz; Eva Kis; Ami B Bhatt; Barbara R Pober
Journal:  Hypertension       Date:  2013-10-14       Impact factor: 10.190

5.  Trends and disparities in stroke mortality by region for American Indians and Alaska Natives.

Authors:  Linda J Schieb; Carma Ayala; Amy L Valderrama; Mark A Veazie
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

6.  Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic Stroke.

Authors:  Michael J Lyerly; Karen C Albright; Amelia K Boehme; Reza Bavarsad Shahripour; John P Donnelly; James T Houston; Pawan V Rawal; Niren Kapoor; Muhammad Alvi; April Sisson; Anne W Alexandrov; Andrei V Alexandrov
Journal:  South Med J       Date:  2015-07       Impact factor: 0.954

Review 7.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

Review 8.  Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association.

Authors:  Carlos J Rodriguez; Matthew Allison; Martha L Daviglus; Carmen R Isasi; Colleen Keller; Enrique C Leira; Latha Palaniappan; Ileana L Piña; Sarah M Ramirez; Beatriz Rodriguez; Mario Sims
Journal:  Circulation       Date:  2014-07-14       Impact factor: 29.690

Review 9.  C-reactive protein and long-term ischemic stroke prognosis.

Authors:  Reyna L VanGilder; Danielle M Davidov; Kyle R Stinehart; Jason D Huber; Ryan C Turner; Karen S Wilson; Eric Haney; Stephen M Davis; Paul D Chantler; Laurie Theeke; Charles L Rosen; Todd J Crocco; Laurie Gutmann; Taura L Barr
Journal:  J Clin Neurosci       Date:  2013-08-23       Impact factor: 1.961

10.  Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice.

Authors:  Jean-Christophe Copin; Rafaela F da Silva; Rodrigo A Fraga-Silva; Luciano Capettini; Silvia Quintao; Sébastien Lenglet; Graziano Pelli; Katia Galan; Fabienne Burger; Vincent Braunersreuther; Karl Schaller; Maud Deruaz; Amanda E Proudfoot; Franco Dallegri; Nikolaos Stergiopulos; Robson A S Santos; Yvan Gasche; François Mach; Fabrizio Montecucco
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.